Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jan 31, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Cash & Equivalents	0.51	1.11	0.45	0.02
Cash & Short-Term Investments	0.51	1.11	0.45	0.02
Cash Growth	14.78%	148.24%	2318.62%	-
Accounts Receivable	-	0.05	-	-
Other Receivables	0.03	0.04	-	-
Receivables	0.03	0.09	-	-
Prepaid Expenses	0.23	1.01	-	-
Total Current Assets	0.84	2.22	0.45	0.02
Total Assets	0.84	2.22	0.45	0.02
Accounts Payable	0.4	0.38	0.09	-
Accrued Expenses	0.05	0.03	0.04	-
Total Current Liabilities	0.45	0.41	0.13	-
Total Liabilities	0.45	0.41	0.13	-
Common Stock	15.62	8.68	0.05	0
Retained Earnings	-16.94	-8.63	-0.13	-0
Comprehensive Income & Other	1.71	1.75	0.4	0.02
Shareholders' Equity	0.39	1.81	0.32	0.02
Total Liabilities & Equity	0.84	2.22	0.45	0.02
Net Cash (Debt)	0.51	1.11	0.45	0.02
Net Cash Growth	14.78%	148.24%	2318.62%	-
Net Cash Per Share	0.01	0.03	0.13	-
Filing Date Shares Outstanding	59.43	53.83	38.38	-
Total Common Shares Outstanding	57.55	50.71	4.38	-
Working Capital	0.39	1.81	0.32	0.02
Book Value Per Share	0.01	0.04	0.07	-
Tangible Book Value	0.39	1.81	0.32	0.02
Tangible Book Value Per Share	0.01	0.04	0.07	-

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error